Notes in IE #7 115-L01

To Subscribe, use this Key

Status	Last Update	Fields
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-1
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-2
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-3
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-4
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-5
Published	11/16/2023	88e21aad44ba4bfcaf88cedd52459100-oa-6
Published	11/16/2023	66240298f36446bbab285702e7e2c853-oa-1
Published	11/16/2023	66240298f36446bbab285702e7e2c853-oa-2
Published	11/16/2023	66240298f36446bbab285702e7e2c853-oa-3
Published	11/16/2023	66240298f36446bbab285702e7e2c853-oa-4
Published	11/16/2023	b6a8896269e8465d9ace436b417ab00e-oa-1
Published	11/16/2023	b6a8896269e8465d9ace436b417ab00e-oa-2
Published	11/16/2023	NIOSH List of Hazardous DrugsReproductive and Devlopmental Toxicity• Adverse effects observed in {{c1::animal testing at doses near, at, or below…
Published	11/16/2023	NIOSH List of Hazardous DrugsIndividual organizations should create its own list of hazardous drugs• {{c1::Faculty specific }}• Evaluate any {{c1…
Published	11/16/2023	Resources for Evauluating a Drug's Hazard Potential{{c1::Safety Data Sheets}}{{c1::Drug Package Insert}}{{c1::International Agency for Research on Can…
Published	11/16/2023	4167b7b0bf4e42ac99ca7e9de444b0ef-oa-1
Published	11/16/2023	4167b7b0bf4e42ac99ca7e9de444b0ef-oa-2
Published	11/16/2023	4167b7b0bf4e42ac99ca7e9de444b0ef-oa-3
Published	11/16/2023	4167b7b0bf4e42ac99ca7e9de444b0ef-oa-4
Published	11/16/2023	4167b7b0bf4e42ac99ca7e9de444b0ef-oa-5
Published	11/16/2023	Containment RequirementsDrugs on NIOSH list that must follow {{c1::USP 800 requirements}}Any {{c1::HD (hazardous drug) API (active pharmaceutical…
Published	11/16/2023	957a183463e54c3eb704177ec0f1ab1b-oa-1
Published	11/16/2023	Assessment of Risk Must document {{c1::alternative containment strategies for specific dosage forms}}For example: Packaging {{c2::drugs ins…
Published	11/16/2023	USP 800 - Potential Exposure{{c1::Receiving hazardous drugs}} Contact {{c2::with drug residue on containers, work surfaces, etc.}}{{c1::Dispensing ha…
Published	11/16/2023	USP 800Designated areas for• {{c1::Receipt, unpacking, storage, compounding}}Hazardous drugs must be unpacked in {{c1::neutral or negative p…
Published	11/16/2023	USP 800 - Engineering Controls{{c1::Containment secondary engineering control(C-SEC) requirements for hazardous drugs}} {{c2::Externally vented}} {{…
Published	11/16/2023	USP 800 - Engineering Controls{{c1::Containment primary engineering controls (C-PEC)}} Sterile: {{c2::externally vented (Class II BSC or CACI)}} Non…
Published	11/16/2023	What is BSC?
Published	11/16/2023	What is CACI?
Published	11/16/2023	What is CSTD?
Published	11/16/2023	What is CVE?
Published	11/16/2023	USP 800 - PPEThe following required when compounding sterile and non-sterile hazardous drugs:• {{c1::Gowns}}• {{c1::Head cover}}• {{c1::Hair…
Published	11/16/2023	ee65928f8fea43ca9c574941a40ecc10-oa-1
Published	11/16/2023	ee65928f8fea43ca9c574941a40ecc10-oa-2
Published	11/16/2023	ee65928f8fea43ca9c574941a40ecc10-oa-3
Published	11/16/2023	ee65928f8fea43ca9c574941a40ecc10-oa-4
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-1
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-2
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-3
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-4
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-5
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-6
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-7
Published	11/16/2023	d6eee6390df74cb09f03ae2558c4234f-oa-8
Status	Last Update	Fields